Kura Oncology Inc Share Price Today: Live Updates & Key Insights

Kura Oncology Inc share price today is $8.42, up -2.02%. The stock opened at $8.485 against the previous close of $8.43, with an intraday high of $8.6 and low of $8.18.

Kura Oncology Inc Share Price Chart

Kura Oncology Inc

us-stock
To Invest in {{usstockname}}
us-stock

Kura Oncology Inc Share Price Performance

$8.42 -0.0202(-2.02%) KURA at 23 Mar 2026 01:54 PM Biotechnology
Lowest Today 8.18
Highest Today 8.6
Today’s Open 8.485
Prev. Close 8.43
52 Week High 12.49
52 Week Low 5.41
Day’s Range: Low 8.18 High 8.6
52-Week Range: Low 5.41 High 12.49
1 day return -
1 Week return -5.38
1 month return -1.01
3 month return -26.64
6 month return +2.22
1 year return +7.97
3 year return -31.36
5 year return -70.12
10 year return -

Kura Oncology Inc Institutional Holdings

BlackRock Inc 10.77

Bvf Inc 9.76

Suvretta Capital Management, LLC 9.71

Vanguard Group Inc 6.24

Armistice Capital, LLC 5.59

State Street Corp 3.78

State Street® SPDR® S&P® Biotech ETF 3.53

AQR Capital Management LLC 3.47

Vanguard Total Stock Mkt Idx Inv 3.09

The Goldman Sachs Group Inc 2.96

Prosight Management, LP 2.86

Geode Capital Management, LLC 2.30

Jacobs Levy Equity Management, Inc. 2.29

iShares Russell 2000 ETF 2.23

Renaissance Technologies Corp 2.07

Morgan Stanley - Brokerage Accounts 2.05

HBM Healthcare Investments AG Ord 1.91

Millennium Management LLC 1.79

Alethea Capital Management, LLC 1.57

Qube Research & Technologies 1.51

Assenagon Asset Management SA 1.30

American Century Companies Inc 1.26

Dimensional Fund Advisors, Inc. 1.22

Acadian Asset Management LLC 1.20

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Invesco MSCI World ETF 1.02

Rhenman Healthcare Equity L/S RC2 SEK 0.99

Fidelity Small Cap Index 0.90

iShares Russell 2000 Value ETF 0.81

Avantis US Small Cap Value ETF 0.74

iShares Biotechnology ETF 0.72

Fidelity Extended Market Index 0.54

State St Russell Sm/Mid Cp® Indx SL Cl I 0.53

BlackRock Advantage Small Cap Core Instl 0.52

Schwab US Small-Cap ETF™ 0.48

Vanguard Russell 2000 ETF 0.43

Sector Healthcare Value A USD 0.37

Multi-Manager Small Cap Eq Strat Inst 0.37

Dimensional US Small Cap ETF 0.32

State St Russell Sm Cap® Indx SL Cl I 0.30

Kura Oncology Inc Market Status

Strong Buy: 10

Buy: 3

Hold: 2

Sell: 0

Strong Sell: 0

Kura Oncology Inc Fundamentals

Market Cap 729.60 M

PB Ratio 4.2761

PE Ratio 0.0

Enterprise Value 97.84 M

Total Assets 738.36 M

Volume 2695440

Kura Oncology Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-142959000 -143.0M, FY22:-136069000 -136.1M, FY21:-129908000 -129.9M, FY20:-89431000 -89.4M, FY19:-63140000 -63.1M

Quarterly Revenue Q3/2025:20750000 20.8M, Q2/2025:15288000 15.3M, Q1/2025:14108000 14.1M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:17538000 17.5M, Q2/2025:15288000 15.3M, Q1/2025:14108000 14.1M, Q3/2024:null 0.0M, Q2/2024:-202000 -0.2M

Quarterly Net worth Q3/2025:-74116000 -74.1M, Q2/2025:-66122000 -66.1M, Q1/2025:-57429000 -57.4M, Q3/2024:-54404000 -54.4M, Q2/2024:-50837000 -50.8M

About Kura Oncology Inc & investment objective

Company Information Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

Organisation Biotechnology

Employees 260

Industry Biotechnology

CEO Dr. Troy Edward Wilson J.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Kura Oncology Inc FAQs

What is the share price of Kura Oncology Inc today?

The current share price of Kura Oncology Inc is $8.42.

Can I buy Kura Oncology Inc shares in India?

Yes, Indian investors can buy Kura Oncology Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Kura Oncology Inc shares in India?

You can easily invest in Kura Oncology Inc shares from India by:

Can I buy fractional shares of Kura Oncology Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Kura Oncology Inc?

Kura Oncology Inc has a market cap of $729.60 M.

In which sector does Kura Oncology Inc belong?

Kura Oncology Inc operates in the Biotechnology sector.

What documents are required to invest in Kura Oncology Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Kura Oncology Inc?

The PE ratio of Kura Oncology Inc is N/A and the PB ratio is 4.28.